CoChat

MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18

Open access
Salcedo, Rosalba, Worschech, Andrea, Cardone, Marco, Jones, Yava, Gyulai, Zsofia, Dai, Ren-Ming, Wang, Ena, Ma, Winnie, Haines, Diana, O'hUigin, Colm, Marincola, Francesco M., Trinchieri, Giorgio · 2010 · Journal of Experimental Medicine

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.

Abstract

Signaling through the adaptor protein myeloid differentiation factor 88 (MyD88) promotes carcinogenesis in several cancer models. In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC). The inability of Myd88(-/-) mice to heal ulcers generated upon injury creates an altered inflammatory environment that induces early alterations in expression of genes encoding proinflammatory factors, as well as pathways regulating cell proliferation, apoptosis, and DNA repair, resulting in a dramatic increase in adenoma formation and progression to infiltrating adenocarcinomas with frequent clonal mutations in the beta-catenin gene. Others have reported that toll-like receptor (Tlr) 4-deficient mice have a similar susceptibility to colitis to Myd88-deficient mice but, unlike the latter, are resistant to CAC. We have observed that mice deficient for Tlr2 or Il1r do not show a differential susceptibility to colitis or CAC. However, upon AOM/DSS treatment Il18(-/-) and Il18r1(-/-) mice were more susceptible to colitis and polyp formation than wild-type mice, suggesting that the phenotype of Myd88(-/-) mice is, in part, a result of their inability to signal through the IL-18 receptor. This study revealed a previously unknown level of complexity surrounding MyD88 activities downstream of different receptors that impact tissue homeostasis and carcinogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20100199

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Myd88−/− mice develop colonic polyps after AOM/DSS administration. Cohorts of 8–10 WT and Myd88−/− mice per group were injected i.v. with AOM on day 0 followed by two DSS cycles administered in drinking water. At the completion of the first DSS cycle, mice were monitored for bleeding (A) and diarrhea (B). 60 d after AOM administration, hematocrits were measured (C), mice were euthanized and colons were resected and measured (D), and macroscopic polyps were counted (E). Colon sections were fixed in formalin and stained with hematoxylin-eosin. Sections were analyzed for inflammation degree (F), extent of ulceration (G), and squamous metaplasia (H). The data shown correspond to a representative experiment out of four performed. Data represent means ± SE (and in some panels also individual mice results). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 1. Myd88−/− mice develop colonic polyps after AOM/DSS administration. Cohorts of 8–10 WT and Myd88−/− mice per group were injected i.v. with AOM on day 0 followed by two DSS cycles administered in drinking water. At the completion of the first DSS cycle, mice were monitored for bleeding (A) and diarrhea (B). 60 d after AOM administration, hematocrits were measured (C), mice were euthanized and colons were resected and measured (D), and macroscopic polyps were counted (E). Colon sections were fixed in formalin and stained with hematoxylin-eosin. Sections were analyzed for inflammation degree (F), extent of ulceration (G), and squamous metaplasia (H). The data shown correspond to a representative experiment out of four performed. Data represent means ± SE (and in some panels also individual mice results). *, P < 0.05; **, P < 0.01; ***, P < 0.001.CC BY-NC-SA · PubMed Central
Figure 2. AOM/DSS treatment of Myd88−/− mice results in decreased proliferation and enhanced apoptosis of colonic epithelial cells and increased expression of mitogenic, angiogenic, and pro-tumorigenic genes. Cohorts of 10 WT and Myd88−/− mice were injected i.v. with AOM on day 0 followed by 3 d of DSS administration in drinking water. Thereafter, colons were resected, fixed in formalin, and sections were stained with Ki67 or ApopTag antibodies. Photomicrographs of representative sections from the respective groups are shown at 400× magnification (A). The number of proliferating cells per crypt and the number of apoptotic cells was determined by counting 20 consecutive crypts/section (B and C). Gene expression profile in colon tissue after AOM/DSS treatment was analyzed by real-time RT-PCR. The gene expression was normalized to Gapdh levels, and the expression of each gene relative to untreated WT mice is depicted (D). The data shown in A–D correspond to a representative experiment out of two performed. Data represent means ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 2. AOM/DSS treatment of Myd88−/− mice results in decreased proliferation and enhanced apoptosis of colonic epithelial cells and increased expression of mitogenic, angiogenic, and pro-tumorigenic genes. Cohorts of 10 WT and Myd88−/− mice were injected i.v. with AOM on day 0 followed by 3 d of DSS administration in drinking water. Thereafter, colons were resected, fixed in formalin, and sections were stained with Ki67 or ApopTag antibodies. Photomicrographs of representative sections from the respective groups are shown at 400× magnification (A). The number of proliferating cells per crypt and the number of apoptotic cells was determined by counting 20 consecutive crypts/section (B and C). Gene expression profile in colon tissue after AOM/DSS treatment was analyzed by real-time RT-PCR. The gene expression was normalized to Gapdh levels, and the expression of each gene relative to untreated WT mice is depicted (D). The data shown in A–D correspond to a representative experiment out of two performed. Data represent means ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001.CC BY-NC-SA · PubMed Central
Figure 3. AOM/DSS treatment enhances mucosal expression of COX-2 and phospho-STAT3 in Myd88−/− mice. Cohorts of 5–10 mice were subjected to treatment as indicated in Fig. 2. At day 3 of DSS administration, colons were resected and fixed in formalin or snap frozen for protein extraction. Tissue sections were stained for COX-2 and pSTAT3. Photomicrographs of representative sections from the respective groups are shown at 200× (A). Protein extracts were analyzed by Western blotting for COX-2, STAT3, and pSTAT3 expression. Gapdh was used as a control (B). The data shown in A and B correspond to a representative experiment out of two performed.
Figure 3. AOM/DSS treatment enhances mucosal expression of COX-2 and phospho-STAT3 in Myd88−/− mice. Cohorts of 5–10 mice were subjected to treatment as indicated in Fig. 2. At day 3 of DSS administration, colons were resected and fixed in formalin or snap frozen for protein extraction. Tissue sections were stained for COX-2 and pSTAT3. Photomicrographs of representative sections from the respective groups are shown at 200× (A). Protein extracts were analyzed by Western blotting for COX-2, STAT3, and pSTAT3 expression. Gapdh was used as a control (B). The data shown in A and B correspond to a representative experiment out of two performed.CC BY-NC-SA · PubMed Central
Figure 4. Increased DNA damage is elicited by AOM/DSS treatment in Myd88−/− mice compared with WT mice. RNA was extracted from cohorts of 10 WT or Myd88−/− mice per group treated with AOM/DSS and from cohorts of six nontreated WT or Myd88−/− mice/group. Samples were processed using the Affymetrix microarray platform, and analyzed using the Ingenuity Pathway and Cluster and TreeView Programs. A significant decrease in DNA repair gene expression profile was observed in Myd88−/− mice after AOM/DSS treatment compared with treated WT mice (A and B). The data shown in A and B were obtained from the microarray experiment that was performed once. The pattern of DNA repair gene expression was subsequently confirmed using real-time RT-PCR. The gene expression was normalized to Gapdh levels, and the expression of each gene relative to untreated WT mice is depicted. One out of two representative experiments is shown (C). Data represent means ± SE. **, P < 0.01; ***, P < 0.001. For analysis of β-catenin mutations, cohorts of 15–20 mice/group were subjected to AOM/DSS treatment (two DSS/cycles). 60 d after AOM administration, individual polyps were resected, and DNA was extracted and analyzed for mutation of β-catenin using specific primers for exon 3. The numbers of polyps exhibiting point mutations at positions 33, 34, 37, and 41 in exon 3 are indicated in the scheme by the stars (D). The polyps analyzed for β-catenin mutations were obtained from multiple experiments and each polyp was sequenced for mutations once.
Figure 4. Increased DNA damage is elicited by AOM/DSS treatment in Myd88−/− mice compared with WT mice. RNA was extracted from cohorts of 10 WT or Myd88−/− mice per group treated with AOM/DSS and from cohorts of six nontreated WT or Myd88−/− mice/group. Samples were processed using the Affymetrix microarray platform, and analyzed using the Ingenuity Pathway and Cluster and TreeView Programs. A significant decrease in DNA repair gene expression profile was observed in Myd88−/− mice after AOM/DSS treatment compared with treated WT mice (A and B). The data shown in A and B were obtained from the microarray experiment that was performed once. The pattern of DNA repair gene expression was subsequently confirmed using real-time RT-PCR. The gene expression was normalized to Gapdh levels, and the expression of each gene relative to untreated WT mice is depicted. One out of two representative experiments is shown (C). Data represent means ± SE. **, P < 0.01; ***, P < 0.001. For analysis of β-catenin mutations, cohorts of 15–20 mice/group were subjected to AOM/DSS treatment (two DSS/cycles). 60 d after AOM administration, individual polyps were resected, and DNA was extracted and analyzed for mutation of β-catenin using specific primers for exon 3. The numbers of polyps exhibiting point mutations at positions 33, 34, 37, and 41 in exon 3 are indicated in the scheme by the stars (D). The polyps analyzed for β-catenin mutations were obtained from multiple experiments and each polyp was sequenced for mutations once.CC BY-NC-SA · PubMed Central
Figure 5. AOM/DSS treatment induces increased frequency of colonic adenocarcinomas in Myd88−/− mice. Cohorts of 15 Myd88−/− mice and 20 WT mice were injected i.v. with AOM on day 0 followed by a single DSS cycle. Animals were monitored during 6 mo after treatment for survival (P = 0.0005, WT vs. Myd88−/−; A). All the colons were analyzed for polyps when mice reached any of the end points for euthanasia or at the completion of the experiment (***, P < 0.001; B). Colon sections were fixed and stained with hematoxylin-eosin. 17 polyps from the WT group and 52 polyps from Myd88−/− knockout mice were analyzed histologically. Photomicrographs of representative sections from the respective groups are shown at 20× (C). The percentage of mice developing adenocarcinomas is indicated (D). Photomicrographs of representative adenocarcinomas from multiple of those that developed in Myd88−/− mice are shown at 40× magnification (E–G). The data shown in this figure were obtained from a single experiment performed treating the mice with one DSS cycle but closely mimic the data obtained from two other independent experiments with mice treated with two DSS cycles that are shown in Fig. S1.
Figure 5. AOM/DSS treatment induces increased frequency of colonic adenocarcinomas in Myd88−/− mice. Cohorts of 15 Myd88−/− mice and 20 WT mice were injected i.v. with AOM on day 0 followed by a single DSS cycle. Animals were monitored during 6 mo after treatment for survival (P = 0.0005, WT vs. Myd88−/−; A). All the colons were analyzed for polyps when mice reached any of the end points for euthanasia or at the completion of the experiment (***, P < 0.001; B). Colon sections were fixed and stained with hematoxylin-eosin. 17 polyps from the WT group and 52 polyps from Myd88−/− knockout mice were analyzed histologically. Photomicrographs of representative sections from the respective groups are shown at 20× (C). The percentage of mice developing adenocarcinomas is indicated (D). Photomicrographs of representative adenocarcinomas from multiple of those that developed in Myd88−/− mice are shown at 40× magnification (E–G). The data shown in this figure were obtained from a single experiment performed treating the mice with one DSS cycle but closely mimic the data obtained from two other independent experiments with mice treated with two DSS cycles that are shown in Fig. S1.CC BY-NC-SA · PubMed Central
Figure 6. Il18 deficiency mimics MyD88 deficiency susceptibility to polyp formation. Cohorts of 6–20 mice/group were subjected to AOM/DSS treatment as depicted by the scheme. At the end of the first DSS cycle, mice were analyzed for bleeding (A). 100 d after AOM administration, the Il1r1−/−, Il18−/−, and their corresponding controls were euthanized and colonic polyps were counted (B). For comparison, Myd88−/− mice were tested simultaneously. Because of their susceptibility to the treatment, the number of polyps was scored at the completion of the second DSS cycle (C). The data shown in A–C correspond to a representative experiment out of three performed. Il18−/− and Il1r−/− mice and their corresponding heterozygote and WT littermates were subjected to AOM/DSS treatment as indicated by the scheme. At the completion of the experiment, the number of colonic polyps was counted (D and E). The data shown in D and E correspond to a representative experiment out of two performed using littermate controls. Data represent means ± SE. **, P < 0.01; ***, P < 0.001.
Figure 6. Il18 deficiency mimics MyD88 deficiency susceptibility to polyp formation. Cohorts of 6–20 mice/group were subjected to AOM/DSS treatment as depicted by the scheme. At the end of the first DSS cycle, mice were analyzed for bleeding (A). 100 d after AOM administration, the Il1r1−/−, Il18−/−, and their corresponding controls were euthanized and colonic polyps were counted (B). For comparison, Myd88−/− mice were tested simultaneously. Because of their susceptibility to the treatment, the number of polyps was scored at the completion of the second DSS cycle (C). The data shown in A–C correspond to a representative experiment out of three performed. Il18−/− and Il1r−/− mice and their corresponding heterozygote and WT littermates were subjected to AOM/DSS treatment as indicated by the scheme. At the completion of the experiment, the number of colonic polyps was counted (D and E). The data shown in D and E correspond to a representative experiment out of two performed using littermate controls. Data represent means ± SE. **, P < 0.01; ***, P < 0.001.CC BY-NC-SA · PubMed Central
Figure 7. Il18-deficient mice exhibit enhanced expression of mitogenic/inflammatory cytokines and STAT-3 phosphorylation after AOM/DSS treatment. Cohorts of 8–10 WT and Il18−/− mice per group were injected i.v. with AOM on day 0, followed by 3 d of DSS administration in drinking water. Thereafter, colons were resected, RNA was extracted, and RT-PCR was performed using specific primers for the indicated genes. The gene expression was normalized to Gapdh levels, and the expression of each gene relative to untreated WT mice is depicted (A). Tissue sections were stained for pSTAT3. Photomicrographs of representative sections from the respective groups are shown at 200× magnification. Protein extracts were analyzed by Western blotting for COX-2, STAT3, and pSTAT3 expression. Gapdh was used as a control (C). Quantification of colonic epithelial cell proliferation and apoptosis was performed in tissue sections stained with Ki67 or ApopTag antibodies. The number of proliferating cells per crypt and the number of apoptotic cells/field are shown. The data shown in A–D correspond to a representative experiment out of two performed. Data represent means ± SE. *, P < 0.05; **, P < 0.01.
Figure 7. Il18-deficient mice exhibit enhanced expression of mitogenic/inflammatory cytokines and STAT-3 phosphorylation after AOM/DSS treatment. Cohorts of 8–10 WT and Il18−/− mice per group were injected i.v. with AOM on day 0, followed by 3 d of DSS administration in drinking water. Thereafter, colons were resected, RNA was extracted, and RT-PCR was performed using specific primers for the indicated genes. The gene expression was normalized to Gapdh levels, and the expression of each gene relative to untreated WT mice is depicted (A). Tissue sections were stained for pSTAT3. Photomicrographs of representative sections from the respective groups are shown at 200× magnification. Protein extracts were analyzed by Western blotting for COX-2, STAT3, and pSTAT3 expression. Gapdh was used as a control (C). Quantification of colonic epithelial cell proliferation and apoptosis was performed in tissue sections stained with Ki67 or ApopTag antibodies. The number of proliferating cells per crypt and the number of apoptotic cells/field are shown. The data shown in A–D correspond to a representative experiment out of two performed. Data represent means ± SE. *, P < 0.05; **, P < 0.01.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

Items 101–200 of 451

Metadata

Authors
Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., & Trinchieri, G.
Affiliations
  • National Cancer Institute (US)
  • National Institutes of Health (US)
  • Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701 1
  • Science Applications International Corporation (United States) (US)
Corresponding author
Trinchieri, Giorgio
Venue
Journal of Experimental Medicine
Published
2010-07-12
Volume
207
Issue
8
Pages
1625-1636
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2118983602
Cited by
429
References
44
Citations by year
2026: 8 · 2025: 12 · 2024: 10 · 2023: 24 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 18 · 2015: 35 · 2014: 36 · 2013: 42 · 2012: 37
FWCI
16.09
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (HHSN261200800001C)
  • National Cancer Institute (HHSN261200800001E))
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
MyD88 signaling, IL-18, interleukin-18 receptor, colitis-associated colorectal cancer, colon adenocarcinoma, carcinogenesis, inflammatory bowel disease, CTNNB1 mutation, adenoma formation, MyD88-deficient mice, TLR2, TLR4, tissue homeostasis
MeSH terms
Adenocarcinoma, Animals, Azoxymethane, Colon, Colonic Neoplasms, Colonic Polyps, Epithelial Cells, Intestinal Mucosa, Mice, Inbred C57BL, Mutation, Phosphorylation, Specific Pathogen-Free Organisms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression, Dextran Sulfate, Apoptosis, Mice, Knockout, Genetic Predisposition to Disease, Interleukin-18, Gene Expression Profiling, DNA Repair Enzymes, Cell Proliferation, STAT3 Transcription Factor, beta Catenin, Mice, Cyclooxygenase 2, Receptors, Interleukin-1 Type I, Myeloid Differentiation Factor 88, Interleukin-18 Receptor alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.